摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

L-磺基丙氨酸 | 498-40-8

中文名称
L-磺基丙氨酸
中文别名
磺基丙氨酸;3-磺基-L-丙氨酸
英文名称
L-Cysteic acid
英文别名
cysteic acid;Cysteinsaeure;L-Cysteinsaeure;(2R)-2-amino-3-sulfopropanoic acid
L-磺基丙氨酸化学式
CAS
498-40-8
化学式
C3H7NO5S
mdl
MFCD00007524
分子量
169.158
InChiKey
XVOYSCVBGLVSOL-REOHCLBHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    260℃ (dec.)
  • 比旋光度:
    [α]D20 +7.5~+9.5° (c=7.4, H2O)
  • 密度:
    1.775±0.06 g/cm3(Predicted)
  • 溶解度:
    甲醇(微溶)、水(微溶)
  • 碰撞截面:
    120.55 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]
  • 稳定性/保质期:

    按规格使用和贮存,不会发生分解,避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    -4.5
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.666
  • 拓扑面积:
    126
  • 氢给体数:
    3
  • 氢受体数:
    6

安全信息

  • 安全说明:
    S26,S36
  • 危险类别码:
    R36/38
  • 危险性防范说明:
    P280,P305+P351+P338,P310
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    密封保存,并放置在通风、干燥的环境中。

SDS

SDS:31d8067f7222755b0605ebb4184d8cca
查看
L-Cysteic Acid Revision number: 1
SAFETY DATA SHEET

Section 1. BASE INFORMATION
Product name: L-Cysteic Acid

Revision number: 1

Section 2. HAZARDS IDENTIFICATION
Classification of the GHS
PHYSICAL HAZARDS Not classified
HEALTH HAZARDS Not classified
Not classified
ENVIRONMENTAL HAZARDS
GHS label elements
None
Pictograms or hazard symbols
Signal word No signal word
None
Hazard statement
Precautionary statements None

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Component(s): L-Cysteic Acid
Percent: >98.0%(T)
CAS Number: 498-40-8
Chemical Formula: C3H7NO5S

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
Protection of first-aiders: A rescuer should wear personal protective equipment, such as rubber gloves and air-
tight goggles.

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Specific hazards: Take care as it may decompose upon combustion or in high temperatures to
generate poisonous fume.
Specific methods: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
L-Cysteic Acid

Section 5. FIRE-FIGHTING MEASURES
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Use personal protective equipment. Keep people away from and upwind of spill/leak.
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

Section 7. HANDLING AND STORAGE
Handling
Handling is performed in a well ventilated place. Wear suitable protective equipment.
Technical measures:
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Storage
Storage conditions: Keep container tightly closed. Store in a cool and dark place.
Store away from incompatible materials such as oxidizing agents.
Packaging material: Law is followed.

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Engineering controls: Install a closed system or local exhaust as possible so that workers should not be
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Protective gloves.
Hand protection:
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Form: crystal - powder
White - Almost white
Color:
Odor: No data available
pH: No data available
Melting point/freezing point:No data available
Boiling Point/Range: No data available
Flash Point: No data available
Explosive limits
Lower: No data available
No data available
Upper:
Density: No data available
No data available
Solubility:

Section 10. STABILITY AND REACTIVITY
Stability: Stable under proper conditions.
Reactivity: No special reactivity has been reported.
Incompartible materials: oxidizing agents
Hazardous Decomposition Carbon monoxide, Carbon dioxide, Nitrogen oxides (NOx), Sulphur oxides
Products:

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
L-Cysteic Acid

Section 11. TOXICOLOGICAL INFORMATION
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
No data available
IARC =
NTP = No data available
No data available
Reproductive toxicity:

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobillity in soil
log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not Listed

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26,
2002): Safe use and production, the storage of a dangerous chemical, transport, loading and unloading were
prescribed.


SECTION 16 - ADDITIONAL INFORMATION
N/A


制备方法与用途

合成制备方法

将胱酸溶于稀盐酸,滴加,反应液温度升至约60℃。在减压下蒸发后,将剩余物溶于蒸馏中,滤去不溶物。滤液浓缩冷却结晶后过滤,用乙醇洗涤滤饼并干燥,得到L-磺基丙氨酸,产率为81-90%。

用途

用于有机合成。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Sloane-Stanley, Biochemical Journal, 1949, vol. 45, p. 557
    摘要:
    DOI:
  • 作为产物:
    描述:
    L-胱氨酸 作用下, 生成 L-磺基丙氨酸
    参考文献:
    名称:
    The Crystal Structure ofl-Cysteic Acid
    摘要:
    半胱氨酸 C3H7NO5S 的晶体结构已经确定。该晶体为正菱形,空间群为 P212121,四个分子位于一个单位晶胞中,其尺寸分别为:a=8.35、b=10.16 和 c=7.44 Å。该分子为齐聚离子 -O3SCH2CH-(NH3+)COOH;其尺寸与其他氨基酸和磺酸的尺寸基本相似。酸性基团占据 Cα-Cβ 键的反式位置,而氨基则处于磺酸基团的顺式位置,并在它们之间形成分子内氢键。
    DOI:
    10.1246/bcsj.41.2305
点击查看最新优质反应信息

文献信息

  • Synthesis of Sulfonyl Chlorides and Sulfonic Acids in SDS Micelles
    作者:Kiumars Bahrami、Mohammad Khodaei、Jamshid Abbasi
    DOI:10.1055/s-0031-1289628
    日期:2012.1
    direct oxidative chlorination of thiol and di­sulfide derivatives to give the desired sulfonyl chlorides. The oxidation of thiols and disulfides to sulfonic acids with this system is also reported. In most cases, these reactions are highly selective, simple, and clean, affording products in excellent yields and high purity. micelles - oxidation - hydrogen peroxide - thiols - solvent systems - amphiphiles
    发现H 2 O 2 / POCl 3是一种反应性试剂体系,可以在性介质中的十二烷基硫酸钠SDS)胶束溶液中使用,用于醇和二键衍生物的直接氧化化,得到所需的磺酰氯。还报道了用该系统将醇和二硫化物氧化为磺酸。在大多数情况下,这些反应具有高度的选择性,简单性和清洁性,可提供具有优异收率和高纯度的产品。 胶束-氧化-过氧化氢-醇-溶剂系统-两亲物
  • Oxidation of thiols by superoxide ion
    作者:G Crank、MIH Makin
    DOI:10.1071/ch9842331
    日期:——

    Superoxide ion oxidizes aromatic thiols to disulfides or sulfonic acids. Benzene-1,2-dithiol and its 4-methyl analogue formed the cyclic disulfides dibenzo[c,g]tetrathiocins. Aliphatic thiols gave disulfides, and ethane-1,2-dithiol and propane-1,3-dithiol formed the cyclic disulfides 1,2,5,6- tetrathiocan and 1,2,6,7-tetrathiecan respectively. Butane-1,4-dithiol underwent an intramolecular cyclization to 1,2-dithian. Cysteine was oxidized by O2-· to cysteic acid.

    超氧离子可将芳香族醇氧化为二硫化物磺酸。苯-1,2-二醇及其 4-甲基类似物形成环状二硫化物二苯并[c,g]四辛酸。脂肪族醇产生 二硫化物乙烷-1,2-二醇和丙烷-1,3-二醇形成环状二硫化物 1,2,5,6- 和 1,2,6,7-Tetrathiecan 的环状二硫化物。1,2,5,6-四杂环烷和 1,2,6,7-四杂环烷。 环化成 1,2-二杂环。半胱酸被 O2 氧化成半胱酸。
  • [EN] HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE<br/>[FR] COMPOSÉS HYDRAZINYL-PYRROLO ET PROCÉDÉS DE PRODUCTION D'UN CONJUGUÉ
    申请人:REDWOOD BIOSCIENCE INC
    公开号:WO2015081282A1
    公开(公告)日:2015-06-04
    The present disclosure provides conjugate structures and hydrazinyl-pyrrolo compound structures used to produce these conjugates. The disclosure also encompasses methods of production of such conjugates, as well as methods of using the same. Aspects of the present disclosure include a pharmaceutical composition. The pharmaceutical composition includes a conjugate as described herein and a pharmaceutically acceptable excipient. Aspects of the present disclosure include a method of delivering a conjugate to a subject. The method includes administering to the subject an effective amount of a conjugate as described herein. Aspects of the present disclosure include a method of treating a condition in a subject.
    本公开提供用于生产这些共轭物的共轭结构和吡咯烷化合物结构。该公开还涵盖了生产这种共轭物的方法,以及使用相同的方法。本公开的方面包括一种药物组合物。该药物组合物包括本文所述的共轭物和药用可接受的赋形剂。本公开的方面包括将共轭物输送给受试者的方法。该方法包括向受试者施用本文所述的共轭物的有效量。本公开的方面包括治疗受试者病症的方法。
  • Tetrahydroimidazo[1,2‐ <i>a</i> ]pyrazine Derivatives: Synthesis and Evaluation as Gα <sub>q</sub> ‐Protein Ligands
    作者:Jim Küppers、Tobias Benkel、Suvi Annala、Kenichi Kimura、Lisa Reinelt、Bernd K. Fleischmann、Evi Kostenis、Michael Gütschow
    DOI:10.1002/chem.202001446
    日期:2020.10
    The 5,6,7,8‐tetrahydroimidazo[1,2‐a]pyrazine derivative BIM‐46174 and its dimeric form BIM‐46187 (1) are heterocyclized dipeptides that belong to the very few cell‐permeable compounds known to preferentially silence Gαq proteins. To explore the chemical space of Gαq inhibitors of the BIM chemotype, a combinatorial approach was conducted towards a library of BIM molecules. This library was evaluated
    5,6,7,8-四氢咪唑并[1,2- a ]吡嗪生物 BIM-46174 及其二聚体形式 BIM-46187 ( 1 ) 是杂环化二肽,属于极少数已知优先沉默 Gα 的细胞渗透性化合物q蛋白。为了探索 BIM 化学型 Gα q抑制剂化学空间,对 BIM 分子库进行了组合方法。该文库在基于第二信使的荧光测定中进行了评估,通过测定细胞内肌醇1-磷酸来分析 Gα q蛋白的活性。推导了结构-活性关系并获得了生物活性的结构要求,它们是(i)氧化还原反应性醇/二烷子结构,(ii)N-末端碱性基,(iii)环己基丙酸部分,和(iv)双环骨架。活性化合物表现出细胞毒性,对此原型抑制剂进行了详细研究1。该化合物以 Gα q/11独立的方式影响结构细胞骨架动力学。
  • Sulfonate derived phosphoramidates as active intermediates in the enzymatic primer-extension of DNA
    作者:S. De、E. Groaz、L. Margamuljana、M. Abramov、P. Marlière、P. Herdewijn
    DOI:10.1039/c5ob00157a
    日期:——

    The incorporation and extension of synthetically unprecedented nucleoside phosphoramidate sulfonates is demonstrated using thermophilic and mesophilic microbial polymerases.

    使用嗜热和中温微生物聚合酶展示了合成前所未有的核苷酸磷酸酰胺磺酸盐的合并和扩展。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸